Archive - Events

up one levelBrussels, 11 May 2006

EPP-ED Hearing on Advanced Therapies




Programme *.docen


Press release:
11/05/2006: Public Hearing on Advanced Therapies: Research, respect for human dignity and integrity of a person must go hand in hand


Interventions:
Cystic Fibrosis and Gene Therapy the global picture… - Marie Johannesson Microsoft PowerPointen
Biopolicy and Regulatory Approaches to Emerging Technologies and the Future of Healthcare - Nigel Cameron *.docen
The New Proposed Regulation - Johann Kurz pdfen
Advanced Therapy Regulation - Dr. Andreas Reimann Microsoft PowerPointen
Advanced Therapy Regulation: A Biotech SME Perspective - Gil Beyen Microsoft PowerPointen
Speech by Emilia Klepackapdfen
The proposed EU regulation from the viewpoint of a Pharmaceutical company with experience in the field of Tissue Engineering - Dr Detlef Niese Microsoft PowerPointen
Regulation on Advanced Therapy Medicinal Products: Eucomed Views - Dario Pirovano Microsoft PowerPointen
Advanced cell therapy : European legislation and discussion - Pr. Colin McGuckin *.docen


Photos:
Public Hearing on Advanced Therapies
Miroslav Mikolášik MEP (EPP-ED, Slovakia), Rapporteur for the Regulation on Advanced Therapies, and Georgette Lalis, European Commission, DG Enterprise and Industry
Public Hearing on Advanced Therapies
Miroslav Mikolášik MEP (EPP-ED, Slovakia), Rapporteur for the Regulation on Advanced Therapies
Public Hearing on Advanced Therapies
Nigel Cameron, President of the Institute on Biotechnology and the Human Future, Research Professor of Bioethics, Associate Dean at Chicago-Kent College of Law, Illinois Institute of Technology
Public Hearing on Advanced Therapies
Miroslav Mikolášik MEP (EPP-ED, Slovakia), Rapporteur for the Regulation on Advanced Therapies (on the right), and Professor Marie Johannesson, President-Elect of the European Cystic Fibrosis Society (ECFS)
Public Hearing on Advanced Therapies
l-r: Peter Liese MEP (EPP-ED, Germany), Miroslav Mikolášik MEP (EPP-ED, Slovakia), Rapporteur for the Regulation on Advanced Therapies, and Georgette Lalis, European Commission, DG Enterprise and Industry
Public Hearing on Advanced Therapies
Public Hearing on Advanced Therapies
View of the meeting room
Public Hearing on Advanced Therapies
Anna Záborská MEP (EPP-ED, Slovakia) (on the right)